131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

NCT04743661 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

62

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Medulloblastoma
Recurrent Ependymoma

Interventions

DRUG: Irinotecan
DRUG: Temozolomide
DRUG: Bevacizumab
DRUG: Omburtamab I-131
DRUG: Liothyronine
DRUG: SSKI
DRUG: Dexamethasone
DRUG: Antipyretic
DRUG: Antihistamine
DRUG: anti-emetics

Sponsor

Pediatric Brain Tumor Consortium

Collaborators

[object Object]
[object Object]
[object Object]